news
Perelel Health, women's vitamin brand, hits $100M run rate
Perelel Health, a supplement company focused on women's reproductive health, announced it hit a $100 million annual run rate. The brand also hired Rare Beauty's former CMO, Katie Welch, signaling aggressive growth plans in the fertility and perimenopause space.
Perelel Health, a supplement company focused on women's reproductive health, announced it hit a $100 million annual run rate. The brand also hired Rare Beauty's former CMO, Katie Welch, signaling aggressive growth plans in the fertility and perimenopause space.
The architecture take
I'm always watching to see where serious money flows, and $100 million for a supplement brand isn't chump change. This isn't just about selling prenatal vitamins anymore; it's a clear signal that the market for targeted hormonal support, especially around fertility and perimenopause, is red-hot. Perelel has carved out a niche by focusing on women's hormonal cycles, from preconception through motherhood and beyond. It means more brands will chase this segment, bringing more products to market specifically for the HPA axis, gut health, and micronutrient demands of reproductive stages. Hiring a big-name CMO from a mainstream beauty brand shows they're not content staying small. They want to own this whole lifecycle. The upside? More specialized options for women. The downside? More noise in an already crowded supplement aisle, and probably higher prices for that 'bespoke' feel.